Kratom, Umbilical Cord, Qualitative
Also known as: KRA QQQ CD
Use
The Kratom, Umbilical Cord, Qualitative test is designed to detect and document fetal exposure to alkaloids found in kratom, an herbal product derived from the Mitragyna speciosa tree or related plants, that occurred during approximately the last trimester of a full-term pregnancy. It specifically identifies the presence of mitragynine and speciociliatine alkaloids in the umbilical cord tissue, indicating the maternal usage of kratom during the pregnancy. The test thus assists in understanding potential drug exposure of the fetus.
Special Instructions
Not provided.
Limitations
This test cannot determine the pattern and frequency of kratom use by the mother and a negative result does not exclude the possibility of kratom usage during pregnancy. Detection of kratom alkaloids depends on the extent of maternal use, stability and characteristics of alkaloid deposition in the umbilical cord tissue, and performance characteristics of the analytical method. The test does not imply impairment or predict outcomes for the infant.
New York Approved
Methodology
Mass Spectrometry
Biomarkers
LOINC Codes
- 101282-2 - Mitragynine TissCo Ql
- 101283-0 - Speciociliatine TissCo Ql
Result Turnaround Time
1-9 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
6 inches
Container
routine urine collection cup or Security Kit
Collection Instructions
Drain and discard any blood. Rinse the exterior of the cord segment with normal saline or water. Pat the cord dry and transport at least 8 inches of umbilical cord in a routine urine collection cup or Security Kit for Meconium/Umbilical Drug Detection.
Causes for Rejection
Cords soaking in blood or other fluid. Formalin fixed. Tissue that is obviously decomposed.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 3 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant